Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution-Non Commercial 3.0 Unported Licence

Crystallographic evidence of a trinuclear (salen)manganese(IV/III/IV)–μ-oxo formed during catalytic C(sp3)–H oxidation reactions

Bhaswati Paul a, Kusalvin Dabare ab, Joshua D. Bocarsly ab and L. Reginald Mills *a
aDepartment of Chemistry, University of Houston, Houston, TX 77204-5003, USA
bTexas Center for Superconductivity, University of Houston, Houston, TX 77204, USA. E-mail: lrmills2@uh.edu

Received 27th November 2025 , Accepted 10th December 2025

First published on 11th December 2025


Abstract

The formation of manganese–oxo catalysts involved in C(sp3)–H bond oxidation was explored in the targeted synthesis of (salen/salophen)manganese complexes that varied axial ligand identity and varied oxidation state of the manganese center. Isolated compounds included dinuclear (salen/salophen)manganese(III)–μ-hydroxo and trinuclear (salen)manganese(IV/III/IV)–μ-oxo, the latter of which formed by oxidation with catalytically relevant oxidant iodosylbenzene. The X-ray structure of trinuclear complex (salen)manganese(IV/III/IV)–μ-oxo indicated a Mn(IV)–O–Mn(III)–O–Mn(IV) motif, with nearly linear Mn–O–Mn angles of 166.19(12)° and 172.47(15)°, Mn(IV)–O bond lengths of 1.948(2) and 1.998(2) Å, and Mn(III)–O bond lengths of 2.102(2) and 2.118(2) Å. All well-defined (salen/salophen)manganese hydroxo and oxo compounds served as precatalysts for oxidation of C(sp3)–H substrates 9,10-dihydroanthracene (>99% conversion), fluorene (52–70% conversion), and phenylcyclohexane (with lower 18–23% conversion), albeit with lower rate of activity for the isolated trinuclear μ-oxo compound, allowing its assignment as an off-cycle catalyst aggregate. These data supported the proposal of a manganese(III/V) cycle for C(sp3)–H oxidation, which involved monomerization of the dinuclear (salen)manganese(III)-μ-hydroxo catalyst prior to rate-determining C(sp3)–H activation.


Introduction

C–H functionalization reactions entail direct transformations of unfunctionalized molecules,1 providing a way to rapidly diversify organic compounds.2 Among strategies for C–H functionalization, reactions that employ hydrogen atom transfer (HAT) enable the activation of C(sp3)-hybridized positions, without the need for directing groups.3 While C(sp3)–H functionalization reactions by free radical intermediates have been long-established in synthetic organic chemistry, many free radicals are inherently reactive and poorly selective for molecules with many C–H bonds.4 Instead of free radical-initiated HAT reactions, an alternative strategy entails the use of transition metal metalloradical catalysts,5 which mimic the reactivity of free-radical intermediates,6 however enable selective catalytic C–H functionalization via steric and electronic modulation of the supporting ligand.

Among metalloradical catalysts for C(sp3)–H functionalization, early chemistry from Kochi and workers demonstrated that salicylaldehyde–ethylamine (salen)-supported manganese complexes catalyzed the C–H oxidation of cyclohexane in the presence of iodosylbenzene.7 A range of catalytic manganese systems have also been demonstrated for metalloradical C(sp3)–H functionalization,8 most prominently (porphyrin)manganese catalysts,9 for instance in undirected C(sp3)–H halogenation10,11 and azidation reactions,12 additionally with lower catalyst loadings compared to prototypical (salen)manganese catalysts.13

A generally proposed mechanism for (salen)manganese(III)-catalyzed C–H oxidation involves generation of (salen)manganese(V)–oxo, which is the reactive catalytic intermediate for C–H oxidation via hydrogen atom abstraction (Scheme 1).14,15 The study of oxomanganese intermediates involved in C–H oxidation has been of interest,16 although the inherently reactive nature of these catalytic intermediates can render isolation challenging.17,18 Early in situ characterization of relevant oxomanganese and hydroxomanganese intermediates has been aided by rapid analytical techniques, for instance spectroscopic detection of (porphyrin)oxomanganese(V) intermediates;19 as well as mass spectrometric detection of (salen)oxomanganese(V) intermediates.20,21 For the isolation of oxomanganese intermediates, synthetic strategies have generally involved sterically demanding supporting ligands that protect the metal center, for instance on the (porphyrin)oxomanganese(V) class,22 or in the non-heme oxomanganese(IV/V) class.23 Among (salen)oxomanganese complexes, isolated oxos are fewer, with notable examples including the sterically demanding, mononuclear (salen)manganese(IV)–hydroxo of Fujii and coworkers,24,25 and the dimeric (salen)manganese(IV)–di-μ-oxo of Fujii and coworkers.26–28


image file: d5dt02844b-s1.tif
Scheme 1 Generally proposed mechanism for (salen/salophen)manganese-catalyzed C(sp3)–H oxidation.

For (salen)manganese C–H oxidation catalysts, outstanding questions include the significance of axial ligand identity (ligand = X in Scheme 1),29,30 especially of type hydroxo, with other systems demonstrating competence of hydroxomanganese complexes for C–H abstraction.31 Namely, while axial ligand identity is proposed to be relevant in the single-step hydrogen atom abstraction reaction of oxomanganese intermediates,32 the impact of axial ligand towards (salen)manganese catalyst turnover is more ambiguous, especially if axial ligand is exchangeable in a complex catalytic mixture. To better understand reactive (salen)manganese intermediates involved in C(sp3)–H oxidation,7,13 herein is reported the targeted synthesis of (salen)manganese-hydroxo and -oxo complexes derived of Jacobsen's catalyst, the reactivity of the isolated compounds towards organic C(sp3)–H substrates in the presence of iodosylbenzene, and insights into the speciation of (salen)oxomanganese during catalysis.

Results and discussion

In the interest of exploring the reactivity of salen-supported manganese catalysts for C(sp3)–H oxidation, initial syntheses explored variation of the axial ligand of the catalyst complex (Scheme 2), which was proposed to affect the reactivity of oxomanganese catalytic intermediates.33 Beginning with cation (salen)manganese(III) bis-aqua derived of Jacobsen's catalyst (1a), ligand exchange with sodium pentafluorophenolate resulted in formation of brown solid with identity (salen)manganese(III) pentafluorophenoxide (2) (Scheme 2a). The structure of (salen)manganese(III) pentafluorophenoxide (2) determined by single crystal X-ray diffraction evidenced a mononuclear complex (2) obtained in 92% isolated yield, with a Mn1–OC6F5 bond length of 2.0664(15) Å. Dissolution of the material in benzene-d6 and analysis by 1H NMR spectroscopy demonstrated broad paramagnetic resonances between 17.52 and −26.45 ppm,34 and the complex exhibited a solution-state magnetic moment of 4.8(1)μB, altogether consistent with a high-spin (S = 2) (salen)manganese(III) complex.35
image file: d5dt02844b-s2.tif
Scheme 2 Reactions of (salen/salophen)Mn(III) compounds with (a) sodium pentafluorophenolate and with (b) sodium pyrazolate.

Analogous ligand exchange was targeted using sodium pyrazolate in reactions with (salen)manganese(III) cation (1a) and with (salophen)manganese(III) cation (1b), which resulting in formation of red-brown products (Scheme 2b). Determination of the molecular structures of 3a/3b by X-ray diffraction indicated formation of dimanganese(III) μ-hydroxo monocation complexes (salen/salophen)Mn–(μ-OH)–(salen/salophen)Mn(PF6) (Scheme 2b), reminiscent of the μ-hydroxo triflate complex (salen)Mn(III)–(μ-OH)–(salen)Mn(III)(OTf) synthesized by Kurahashi.36,37 In the solid-state structure of the salophen derivative (3b), cocrystallization of two dimanganese(III) μ-hydroxo monocations was observed (Fig. S21), one of which bore a capping pyrazole ligand (3b-PzH) (Fig. 1). The X-ray structure of 3b-PzH indicated two manganese(III) centers, a bridging OH group, and a single pyrazole ligand. For the 3b-PzH molecule, the measured Mn–OH bond lengths were 1.991(2) Å and 2.094(2) Å, with a Mn1–O(H)–Mn2 angle of 153.32(14)°, similar to the μ-hydroxo octaethylporphyrinato complex of Fries, Marchon, Scheidt, and coworkers, (OEP)Mn(III)–(μ-OH)–(OEP)Mn(III), which displayed a Mn–O(H)–Mn bridge angle of 152.73(11)°.38,39 For the current complex (3b-PzH), the longer Mn1–N5 bond length of 2.318(4) Å was consistent with weaker manganese(III)–pyrazole coordination, with the pyrazole proposed to undergo dynamic ligand exchange in solution. Dissolution of 3a/3b in benzene-d6 and analysis by 1H NMR spectroscopy indicated broadened signals between 16.46 and −21.71 ppm, consistent with paramagnetic character for the manganese(III)–μ-OH-manganese(III) complexes (3a/3b). In benzene-d6 solution at 298 K, the observed magnetic moments were 5.4(1)μB for 3a and 5.2(1)μB for 3b, lower than the expected spin-only value of 6.9μB for two noninteracting S = 2 Mn(III) centers. In the solid-state, variable temperature SQUID magnetometry for 3b modelled the antiferromagnetic coupling at isotropic g = 2.00 with J = −28.80(3) cm−1, consistent with the coupling observed in related manganese(III)–μ-hydroxo compounds (Fig. 2).40–42 Together, these data evidenced that reaction of (salen/salophen)manganese(III) bis-aqua cation (1a/b) with sodium pyrazolate resulted in water ligand deprotonation rather than pyrazolate coordination, forming the hydroxo-bridged dimanganese(III) complex. Compared to ligand association reaction of less basic sodium pentafluorophenolate (2) (pKa of C6F5OH = 5.5 in H2O),43 these data demonstrate that (salen/salophen)manganese(III) bis-aqua cation is more acidic than pyrazole (pKa = 19.8 in DMSO),44 undergoing deprotonation by basic ligands and limiting the options for synthesis of complexes by ligand exchange with such basic ligands.


image file: d5dt02844b-f1.tif
Fig. 1 Solid-state molecular structure of pyrazole-coordinated (salophen)Mn–(μ-OH)–(salophen)Mn(PzH)(PF6) cation (3b-PzH) determined by X-ray diffraction (30% probability ellipsoids). H atoms, solvent molecules, PF6 counterion, and cocrystallizing molecule of 3b omitted for clarity (see SI for details). Hydrogen atom H5 was located and freely refined. Select bond lengths (Å) and angles (°): Mn1–O5 2.094(2); Mn2–O5 1.991(2); Mn1–N5 2.318(4); Mn1–O5–Mn2 153.32(14).

image file: d5dt02844b-f2.tif
Fig. 2 Variable-temperature SQUID magnetization for (salophen)Mn–μ-OH–(salophen)Mn(PF6) (3b) recorded in the solid state. Magnetic field = 200 Oe. Simulation parameters: giso = 2.00, J = −28.80(3) cm−1.

The deprotonation of (salen)manganese(III) bis-aqua cation (1a) with sodium pyrazolate can be compared with the same deprotonation employing aqueous KOH instead of NaPz, reported by Fujii and coworkers to form dimanganese(IV) di-μ-oxo (4) in the presence of air.26 Repeating the procedure of Fujii and coworkers employing 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) as base in acetonitrile open to air, full conversion of bis-aqua complex (1a) was determined by 1H NMR spectroscopy in acetonitrile-d3 (eqn (1)), with the identity of the product verified by X-ray diffraction (Fig. S26).26,45 These results demonstrate that deprotonation of bis-aqua complex (1a) in the presence of air results in oxidation to a di-μ-oxo, which is distinct from the desired terminal (salen)manganese(V)–oxo catalytic intermediate often proposed in C(sp3)–H oxidation reactions.

 
image file: d5dt02844b-u1.tif(1)

After isolation of (salen/salophen)manganese(III)–μ-hydroxo compounds (3a/3b), the synthesis of higher oxidation state (salen)manganese complexes relevant to C–H oxidation was targeted (Scheme 3). In a one-pot procedure, after formation of (salen)manganese(III)–μ-hydroxo (3a), treatment with oxidant iodosylbenzene under air resulted in conversion to a crystalline brown solid (5), which displayed broad paramagnetic resonances between 11.64 and −14.29 ppm by 1H NMR spectroscopy in acetonitrile-d3 (Scheme 3). After isolation of single crystals suitable for X-ray diffraction, the solid-state structure was determined to be a trinuclear monocationic complex consisting of two oxidized (salen)manganese(IV) centers at the ends (Mn1, Mn3), a (salen)manganese(III) atom in the middle (Mn2), and two μ-oxos (O1, O2) bridging the (salen)manganese atoms (Fig. 3).46 The manganese(IV)–oxo bond lengths (1.998(2) Å, 1.948(2) Å) were shorter than the manganese(III)–oxo bond lengths (2.102(2) Å, 2.118(2) Å), consistent with Mn(IV)[double bond, length as m-dash]O double-bond character and Mn(III)–O single-bond character, which was apparent in the direct comparison of Mn–O(H/R) bond lengths for the series of complexes (salen)Mn(III)(OH2)2, 2, 3a, and 5 (Table 1). Comparison of these complexes also informed highly conserved bond lengths across the organic salen ligand framework (O–Caryl and OarylC[double bond, length as m-dash]CCimine), demonstrating identical electronic structures on the salen supporting ligand, with any electronic differences between complexes occurring primarily at the manganese center (Table 1). The Mn(IV/III/IV) assignment of (salen)manganese(IV/III/IV)–μ-oxo compound (5) was further corroborated by a Mn 3s doublet separation of 5.0 eV measured by XPS (Fig. S61),47 demonstrating (salen)manganese(IV/III/IV)–μ-oxo (5) to be the thermodynamic product of (salen)manganese(III)–μ-hydroxo (3a) oxidation using iodosylbenzene.


image file: d5dt02844b-s3.tif
Scheme 3 Synthesis of trinuclear (salen)manganese(IV/III/IV)–μ-oxo (5).

image file: d5dt02844b-f3.tif
Fig. 3 Front-view (left) and side-view (right) of the solid-state molecular structure of 5 determined by single crystal X-ray diffraction (30% probability ellipsoids). H atoms, solvent molecules, and PF6 counterion omitted for clarity. Select bond-lengths (Å) and angles (°): Mn1–O1 1.998(2); Mn2–O1 2.102(2); Mn2–O2 2.118(2); Mn3–O2 1.948(2); Mn1–O1–Mn2 166.19(12); Mn2–O2–Mn3 172.47(15).
Table 1 Selected bond lengths (Å) for (salen)manganese complexes determined by X-ray diffraction
Compound Mn–O(H/R) OAryl–Mn NImine–Mn O–CAryl OArylC[double bond, length as m-dash]CCImine
(salen)Mn(OH2)(dioxane)(ClO4)48 2.269 1.860 1.979 1.329 1.409
1.860 1.980 1.316 1.400
2 2.0664(15) 1.8692(15) 1.9773(16) 1.321(2) 1.418(3)
1.8747(14) 1.9909(18) 1.329(3) 1.418(3)
3a 2.0355(18) 1.868(3) 1.998(4) 1.336(6) 1.413(7)
1.869(4) 1.973(4) 1.331(6) 1.409(7)
5 1.998(2) 1.870(2) 1.979(3) 1.318(4) 1.417(4)
2.102(2) 1.879(2) 1.986(3) 1.319(4) 1.414(4)
2.118(2) 1.892(2) 1.994(3) 1.314(4) 1.417(4)
1.948(2) 1.877(2) 1.986(3) 1.315(4) 1.418(4)
1.882(2) 1.979(3) 1.320(4) 1.423(5)
1.866(2) 1.972(3) 1.317(4) 1.422(4)


The formation of (salen)manganese(IV/III/IV)–μ-oxo (5) was rationalized by an oxidation/comproportionation sequence (Scheme 4). Namely, upon treatment of (salen)manganese(III)–μ-hydroxo (3a) with PhIO, the initial product of (salen)manganese oxidation is proposed to be terminal (salen)manganese(V)–oxo (6a). In the presence of excess (salen)manganese(III) (3a), comproportionation, proton transfer, and ligand redistribution generates trinuclear (salen)manganese(IV/III/IV)–μ-oxo (5), which precipitates from solution as a crystalline brown solid, concomitant with (salen)manganese(III) cation (1a) that can further react with excess sodium pyrazolate and iodosylbenzene. These reactions establish kinetically accessible axial ligand exchange after reaction with iodosylbenzene, indicating formation of thermodynamic oxidized (salen)manganese products according to presence of oxidant.


image file: d5dt02844b-s4.tif
Scheme 4 Rationalized intermediates leading to trinuclear complex formation.

In the solid state, variable temperature SQUID magnetization measured for (salen)manganese(IV/III/IV)–μ-oxo (5) established significant antiferromagnetic coupling between the three high-spin manganese centers, simulated at isotropic g = 2.00 with a coupling constant of J = −61.1(2) cm−1 (Fig. 4). This value was comparable to the coupling observed for other manganese(IV/III)–μ-oxos,49,50 and compared to the (salophen)manganese(III)–μ-hydroxo (3b, J = −28.80(3) cm−1) is consistent with more significant superexchange interaction expected for the bridging μ-oxo (5).42 The solid state moment matched the acetonitrile-d3 solution-state magnetic moment of μeff = 5.4(1)μB at 298 K, consistent with antiferromagnetic coupling and fidelity of the trinuclear complex upon dissolution in acetonitrile-d3. This fidelity was exemplified upon incubation of equimolar (salen)manganese(IV/III/IV)–μ-oxo (5) with (salophen)manganese–μ-hydroxo (3b) in acetonitrile-d3 at ambient temperature, which resulted in no apparent ligand exchange between the complexes by 1H NMR spectroscopy after 1 h (Fig. S35). These data altogether indicate that trinuclear (salen)manganese(IV/III/IV)–μ-oxo (5) is a thermodynamic, stable product of (salen)manganese(III)–μ-hydroxo oxidation.


image file: d5dt02844b-f4.tif
Fig. 4 Temperature-dependent SQUID magnetization for (salen)Mn(IV/III/IV)–μ-oxo (5) recorded in the solid state. Magnetic field = 200 Oe. Simulation parameters: giso = 2.00, J = −61.1(2) cm−1.

With some isolated (salen)manganese compounds in hand, their relevance was determined in C(sp3)–H oxidation reactions employing iodosylbenzene, demonstrating that all isolated compounds served as precatalysts (Table 2). As model reaction in 9[thin space (1/6-em)]:[thin space (1/6-em)]1 acetonitrile/water mixture open to air, one equivalent of the suitable C–H substrate, three equivalents of oxidant, and 10 mol% (per Mn center) of the appropriate (salen/salophen)manganese compound were stirred at ambient temperature until reaction progression halted, as judged by GC-MS analysis of reaction aliquots. Both PF6 bis-aqua cations (salen)manganese (1a) and (salophen)manganese (1b) gave similar reactivity, with full conversion of 9,10-dihydroanthracene (DHA), 68–70% conversion of fluorene, and partial conversion (20–22%) of phenylcyclohexane (Table 2, entries 1 and 2). Employing 10 mol% per Mn center of newly isolated (salen/salophen)manganese compounds (2, 3a–b, 5) resulted in comparable conversions of the three substrates in all cases (±15%) (entries 3–6). Importantly, these data demonstrated the catalytic competence of (salen/salophen)manganese μ-hydroxo (3a–b) and (salen)manganese(IV/III/IV) μ-oxo (5) compounds, the latter of which was synthesized with the catalytically relevant oxidant, iodosylbenzene. Together, these results implicated the observed coordination chemistry of μ-hydroxo (3a–b) and μ-oxo (5) as reflecting the coordination chemistry of the active (salen)manganese catalyst that engages turnover-limiting C(sp3)–H oxidation.

Table 2 Evaluation of well defined salen/salophen Mn catalysts for C–H oxidation

image file: d5dt02844b-u2.tif

Entry Mn compound C–H substrate conversiona
DHA Fluorene CyPh
a Conversions determined by GC-MS. DHA = 9,10-dihydroanthracene. b KIE(1/2H) = 3.1(6). c KIE(1/2H) = 1.9(2). d KIE(1/2H/D) = 3.1(3).
1 1a (10 mol%) >99%b 68% 20%
2 1b (10 mol%) >99% 70% 22%
3 2 (10 mol%) >99% 80% 18%
4 3a (5 mol%) >99%c 52% 22%
5 3b (5 mol%) >99% 58% 23%
6 5 (3.3 mol%) >99%d 65% 18%


The catalytic competence of (salen)manganese complexes of different nuclearity (1a, 3a, 5) raised a question about catalyst nuclearity, since studies thus far indicated that isolated dinuclear (3a/b) and trinuclear (5) compounds were metastable in acetonitrile-d3 solution as determined by 1H NMR spectroscopy. Namely, when starting from different precatalysts (1a, 3a, 5), could the same C(sp3)–H oxidation catalysts be generated in situ, or would different catalysts be formed in all cases? By UV-vis absorption spectroscopy, discrimination of the isolated (salen)manganaese compounds was apparent, with (salen)manganese(III) cation (1a) exhibiting a peak at 367 nm, and both (salen)manganese(III)–μ-hydroxo (3a) and (salen)manganese(IV/III/IV)–μ-oxo (5) exhibiting peaks at 420 nm (Fig. 5a). When using the isolated compounds (1a, 3a, 5) as precatalysts for oxidation of DHA with PhIO, the UV-vis spectra of the catalytic reaction mixtures were identical, exhibiting a conserved peak at 445 nm, indicating identical catalyst speciation regardless of initial axial ligand identity (Fig. 5b). In parallel time courses, the initial rates of 9,10-DHA conversion were also comparable between precatalysts, with parent (salen)manganese(III) cation (1a) displaying a slightly faster rate (ca. 2.9 times faster than 5) (Fig. 5c). While the precise identity of the active catalyst for C(sp3)–H oxidation was not apparent from spectroscopic studies, initial rate kinetics indicated approximate first-order dependence according to initial concentration of 1a, and partial order dependence on concentration of [Mn] center when employing either 3a or 5, implying that dinuclear and trinuclear intermediates are not directly active for rate-determining C(sp3)–H activation, with monomerization preceding the C(sp3)–H activation step (Fig. S57–S59). Altogether, these data further support the observed coordination chemistry of (salen)manganese complexes, which undergo oxidation with iodosylbenzene and subsequently undergo rapid intermolecular axial ligand exchange, leading to the catalytic resting state. For (salen)manganese(IV/III/IV)–μ-oxo (5) in particular, while it is a thermodynamic product of (salen)manganese oxidation by iodosylbenzene, it alone was not kinetically competent for oxidation of 9,10-DHA in a stoichiometric reaction (Fig. S36). Therefore, 5 is more accurately described as an off-cycle catalyst aggregate, which forms in the comproportionation of (salen)manganese(V)-oxo with excess (salen)manganese(III) cation when C(sp3)–H substrate and/or oxidant are depleted.


image file: d5dt02844b-f5.tif
Fig. 5 (a) UV-vis absorption spectra of 1a (100 µM) (red), 3a (50 µM) (blue), and 5 (33 µM) (green) in acetonitrile. (b) UV-Vis spectra of (salen)manganese-catalyzed DHA oxidation (ca. 15% conversion) initiated from 10 mol% 1a, 5 mol% 3a, and 3.3 mol% 5 in acetonitrile/water (9[thin space (1/6-em)]:[thin space (1/6-em)]1). (c) Concentration of 9,10-DHA over time according to precatalyst in reaction with PhIO (3 equiv.); lines represent least-squares fit to a standard kinetic model.

Finally, the catalytic competence of (salen)manganese(III)-μ-hydroxo cation (3a) allowed proposal of a simplified catalytic cycle for C(sp3)–H oxidation (Scheme 5).51 Namely, the synthesis of (salen)manganese(III)-μ-hydroxo cation (3a) evidenced dimerization of the complex prior to oxidation by PhIO. Thus, the starting dimeric μ-hydroxo (3) is oxidized, which initially yields dinuclear (salen)oxomanganese (6) (Scheme 5). Dinuclear (salen)oxomanganese intermediates (6) have previously been proposed as reservoir species for catalytically active mononuclear (salen)manganese(V)–oxo (7),21 which dissociation is proposed to occur in the presence of coordinating solvent.17 Then, turnover-limiting C–H oxidation regenerates (salen)manganese(III) (3), completing the cycle.


image file: d5dt02844b-s5.tif
Scheme 5 Simplified catalytic cycle for (salen)Mn(μ-OH)-catalyzed C–H oxidation.

Conclusions

To investigate (salen)manganese intermediates in C(sp3)–H oxidation, the reaction of (salen)manganese(III)–μ-hydroxo with iodosylbenzene formed trinuclear (salen)manganese(IV/III/IV)–μ-oxo, which was rationalized as a comproportionation product of a (salen)manganese(V)–oxo intermediate with well defined (salen)manganese(III) cation. The isolated (salen)manganese(IV/III/IV)–μ-oxo compound initiated C(sp3)–H oxidation reactions, evidencing manganese–oxo formation as being catalytically relevant. While manganese–oxo formation has been previously proposed or observed with other manganese catalysts, the current compound represents a rare manganese(IV)–μ-oxo on the salen platform that was isolated and characterized crystallographically.

The observed complexes also evidenced thermodynamically favorable dimerization of manganese(III)–μ-hydroxo and manganese(IV/III/IV)–μ-oxo complexes via Mn–O–Mn bridging interactions in the solid state. While oxomanganese intermediates are often drawn as monomeric in C(sp3)–H oxidation reactions, notably many structurally characterized monomeric oxomanganese compounds bear sterically demanding supporting ligands, which may inhibit intermolecular association. Herein, structural characterization was performed on the catalytically relevant (salen)manganese platform derived of commonly employed Jacobsen's catalyst, and the observation of dinuclear and trinuclear complexes with this ligand evidenced that catalysts for C(sp3)–H oxidation may favor aggregation, especially in the absence of productive reactions when substrate or reagent is depleted. Finally, whereas axial ligand identity is proposed to affect the rate of a C–H abstraction step by oxomanganese complexes, herein the axial ligand identity of the (salen)manganese precatalyst bore no apparent impact on catalyst resting state or turnover number, evidencing rapid axial ligand exchange and kinetically accessible (salen)manganese catalyst speciation regardless of precatalyst axial ligand.

Author contributions

B. P. and L. R. M. conceived the work and designed experiments. B. P. performed all experiments. K. D. and J. D. B. assisted with initial collection of SQUID magnetization data. The manuscript was written by all authors.

Conflicts of interest

The authors declare no competing financial interest.

Data availability

Full experimental details and characterization are available in the supplementary information (SI). Supplementary information: general experimental considerations, experimental procedures, spectral characterization data, and supplemental X-ray crystallographic data. See DOI: https://doi.org/10.1039/d5dt02844b.

CCDC 2483878–2483882 contain the supplementary crystallographic data for this paper.52a–e

Acknowledgements

The Texas University Fund is acknowledged for University of Houston start-up funding. J. D. B. acknowledges support from the Welch Foundation (E-2179-20240404). Dr Boris Makarenko (University of Houston) is thanked for assistance with XPS analysis.

References

  1. (a) N. Y. S. Lam, K. Wu and J.-Q. Yu, Angew. Chem., Int. Ed., 2021, 60, 15767–15790 CrossRef CAS PubMed; (b) T. Dalton, T. Faber and F. Glorius, ACS Cent. Sci., 2021, 7, 245–261 CrossRef CAS PubMed.
  2. L. Guillemard, N. Kaplaneris, L. Ackermann and M. J. Johansson, Nat. Rev. Chem., 2021, 5, 522–545 CrossRef CAS PubMed.
  3. M. C. White and J. Zhao, J. Am. Chem. Soc., 2018, 140, 13988–14009 CrossRef CAS PubMed.
  4. D. L. Golden, S.-E. Suh and S. S. Stahl, Nat. Rev. Chem., 2022, 6, 405–427 CrossRef CAS PubMed.
  5. M. R. Bermejo, A. Castiñeiras, J. C. Garcia-Monteagudo, M. Rey, A. Sousa, M. Watkinson, C. A. McAuliffe, R. G. Pritchard and R. L. Beddoes, J. Chem. Soc., Dalton Trans., 1996, 1996, 2935–2944 RSC.
  6. J. M. Mayer, Acc. Chem. Res., 2011, 44, 36–46 CrossRef CAS PubMed.
  7. (a) K. Srinivasan, P. Michaud and J. K. Kochi, J. Am. Chem. Soc., 1986, 108, 2309–2320 CrossRef CAS PubMed; (b) K. Srinivasan, S. Perrier and J. K. Kochi, J. Mol. Catal., 1986, 36, 297–317 CrossRef CAS.
  8. (a) M. Guo, T. Corona, K. Ray and W. Nam, ACS Cent. Sci., 2019, 5, 13–28 CrossRef CAS PubMed; (b) G. Olivo, O. Lanzalunga and S. Di Stefano, Imine-based Iron and Manganese Complexes as Catalysts for Alkane Functionalization, in Alkane Functionalization, ed. A. J. L. Pombeiro and M. F. C. G. da Silva, Wiley, 2018, pp. 231–249 Search PubMed.
  9. (a) B. Meunier, Chem. Rev., 1992, 92, 1411–1456 CrossRef CAS; (b) R. A. Baglia, J. P. T. Zaragoza and D. P. Goldberg, Chem. Rev., 2017, 117, 13320–13352 CrossRef CAS PubMed.
  10. W. Liu and J. T. Groves, J. Am. Chem. Soc., 2010, 132, 12847–12849 CrossRef CAS PubMed.
  11. W. Liu, X. Huang, M.-J. Cheng, R. J. Nielsen, W. A. Goddard and J. T. Groves, Science, 2012, 337, 1322–1325 CrossRef CAS PubMed.
  12. W. Liu and J. T. Groves, Acc. Chem. Res., 2015, 48, 1727–1735 CrossRef CAS PubMed.
  13. X. Huang, T. M. Bergsten and J. T. Groves, J. Am. Chem. Soc., 2015, 137, 5300–5303 CrossRef CAS PubMed.
  14. S. Biswas and A. N. Biswas, High-Valent Oxomanganese Complexes of Relevance in Oxyfunctionalization of Hydrocarbons, in Handbook of CH-Functionalization, ed. M. Debabrata, Wiley-VCH, 2022 Search PubMed.
  15. O. Y. Lyakin, R. V. Ottenbacher, K. P. Bryliakov and E. P. Talsi, Top. Catal., 2013, 56, 939–949 CrossRef CAS.
  16. (a) S. P. de Visser, F. Ogliaro, Z. Gross and S. Shaik, Chem. – Eur. J., 2001, 7, 4954–4960 CrossRef CAS PubMed; (b) F. De Angelis, N. Jin, R. Car and J. T. Groves, Inorg. Chem., 2006, 45, 4268–4276 CrossRef CAS PubMed; (c) D. Balcells, C. Raynaud, R. H. Crabtree and O. Eisenstein, Inorg. Chem., 2008, 47, 10090–10099 CrossRef CAS PubMed.
  17. E. Gallo, E. Solari, N. Re, C. Floriani, A. Chiesi-Villa and C. Rizzoli, Angew. Chem., Int. Ed. Engl., 1996, 35, 1981–1983 CrossRef CAS.
  18. V. A. Larson, B. Battistella, K. Ray, N. Lehnert and W. Nam, Nat. Rev. Chem., 2020, 4, 404–419 CrossRef CAS PubMed.
  19. (a) J. T. Groves and M. K. Stern, J. Am. Chem. Soc., 1988, 110, 8628–8638 CrossRef CAS; (b) J. T. Groves, J. Lee and S. S. Marla, J. Am. Chem. Soc., 1997, 119, 6269–6273 CrossRef CAS; (c) R. Zhang and M. Newcomb, J. Am. Chem. Soc., 2003, 125, 12418–12419 CrossRef CAS PubMed; (d) O. S. Oablyasova, V. Zamudio-Bayer, M. Flach, M. da Silva Santos, J. T. Lau and K. Hirsch, Phys. Chem. Chem. Phys., 2024, 26, 5830–5835 RSC.
  20. D. Feichtinger and D. A. Plattner, Direct Proof for O=MnV(salen) Complexes, Angew. Chem., Int. Ed. Engl., 1997, 36, 1718–1719 CrossRef CAS.
  21. (a) D. Feichtinger and D. A. Plattner, J. Chem. Soc., Perkin Trans. 2, 2000, 1023–1028 RSC; (b) D. Feichtinger and D. A. Plattner, Chem. – Eur. J., 2001, 7, 591–599 CrossRef CAS PubMed.
  22. (a) B. R. Cook, T. J. Reinert and K. S. Suslick, J. Am. Chem. Soc., 1986, 108, 7281–7286 CrossRef CAS; (b) N. Jin and J. T. Groves, J. Am. Chem. Soc., 1999, 121, 2923–2924 CrossRef CAS; (c) W. Nam, I. Kim, M. H. Lim, H. J. Choi, J. S. Lee and H. G. Jang, Chem. – Eur. J., 2002, 8, 2067–2071 CrossRef CAS PubMed; (d) W. J. Song, M. S. Seo, S. DeBeer George, T. Ohta, R. Song, M.-J. Kang, T. Tosha, T. Kitagawa, E. I. Solomon and W. Nam, J. Am. Chem. Soc., 2007, 129, 1268–1277 CrossRef CAS PubMed; (e) S. Fukuzumi, H. Kotani, K. A. Prokop and D. P. Goldberg, J. Am. Chem. Soc., 2011, 133, 1859–1869 CrossRef CAS PubMed.
  23. (a) F. M. MacDonnell, N. L. P. Fackler, C. Stern and T. V. O'Halloran, J. Am. Chem. Soc., 1994, 116, 7431–7432 CrossRef CAS; (b) X. Wu, M. S. Seo, K. M. Davis, Y.-M. Lee, J. Chen, K.-B. Cho, Y. N. Pushkar and W. Nam, J. Am. Chem. Soc., 2011, 133, 20088–20091 CrossRef CAS PubMed; (c) R. L. Halbach, D. Gygi, E. D. Bloch, B. L. Anderson and D. G. Nocera, Chem. Sci., 2018, 9, 4524–4528 RSC; (d) X.-X. Li, M. Guo, B. Qiu, K.-B. Cho, W. Sun and W. Nam, Inorg. Chem., 2019, 58, 14842–14852 CrossRef CAS PubMed; (e) G. Gupta, M. Bera, S. Paul and S. Paria, Inorg. Chem., 2021, 60, 18006–18016 CrossRef CAS PubMed; (f) G. Green, K. U. Ansari, T. Munikrishna, S. Ezov, D. Shamali, L.-N. Nanda, V. Gutkin, O. Cohen, D. Shimon and Y. Tulchinsky, J. Am. Chem. Soc., 2025, 147, 30647–30660 CrossRef CAS PubMed.
  24. T. Kurahashi, A. Kikuchi, T. Tosha, Y. Shiro, T. Kitagawa and H. Fujii, Transient Intermediates from Mn(salen) with Sterically Hindered Mesityl Groups: Interconversion between MnIV-Phenolate and MnIII-Phenoxyl Radicals as an Origin for Unique Reactivity, Inorg. Chem., 2008, 47, 1674–1686 CrossRef CAS PubMed.
  25. T. Kurahashi, A. Kikuchi, Y. Shiro, M. Hada and H. Fujii, Inorg. Chem., 2010, 49, 6664–6672 CrossRef CAS PubMed.
  26. T. Kurahashi, M. Hada and H. Fujii, Inorg. Chem., 2014, 53, 1070–1079 CrossRef CAS PubMed.
  27. H. Chen, R. Tagore, S. Das, C. Incarvito, J. W. Faller, R. H. Crabtree and G. W. Brudvig, Inorg. Chem., 2005, 44, 7661–7670 CrossRef CAS PubMed.
  28. I. Araki, K. Fukui and H. Fujii, Inorg. Chem., 2018, 57, 1685–1688 CrossRef CAS PubMed.
  29. G. Tarantino, T. G. Burrow, M. Aramini, M. L. Baker and C. Hammond, ACS Catal., 2025, 15, 4499–4506 CrossRef CAS.
  30. C. Wu, J. Chen, W. Nam and B. Wang, Coord. Chem. Rev., 2025, 528, e216429 CrossRef.
  31. (a) J. P. T. Zaragoza, M. A. Siegler and D. P. Goldberg, J. Am. Chem. Soc., 2018, 140, 4380–4390 CrossRef CAS PubMed; (b) J. R. Mayfield, E. N. Grotemeyer and T. A. Jackson, Chem. Commun., 2020, 56, 9238–9255 RSC; (c) Y. Lee, G. L. Tripodi, D. Jeong, S. Lee, J. Roithova and J. Cho, J. Am. Chem. Soc., 2022, 144, 20752–20762 CrossRef CAS PubMed; (d) L. Zhang, M. S. Seo, Y. Choi, R. Ezhov, O. Maximova, D. D. Malik, M. Ng, Y.-M. Lee, R. Sarangi, Y. N. Pushkar, K.-B. Cho and W. Nam, J. Am. Chem. Soc., 2023, 145, 8319–8325 CrossRef CAS PubMed.
  32. (a) I. V. Khavrutskii, R. R. Rahim, D. G. Musaev and K. Morokuma, J. Phys. Chem. B, 2004, 108, 3845–3854 CrossRef CAS; (b) W. M. C. Sameera and J. E. McGrady, Dalton Trans., 2008, 2008, 6141–6149 RSC; (c) M. E. Crestoni, S. Fornarini and F. Lanucara, Chem. – Eur. J., 2009, 15, 7863–7866 CrossRef CAS PubMed; (d) D. F. Leto, A. A. Massie, D. B. Rice and T. A. Jackson, J. Am. Chem. Soc., 2016, 138, 15413–15424 CrossRef CAS PubMed.
  33. T. Kurahashi, Inorg. Chem., 2018, 57, 1066–1078 CrossRef CAS PubMed.
  34. Y. Ciringh, S. W. Gordon-Wylie, R. E. Norman, G. R. Clark, S. T. Weintraub and C. P. Horwitz, Inorg. Chem., 1997, 36, 4968–4982 CrossRef CAS.
  35. B. J. Kennedy and K. S. Murray, Inorg. Chem., 1985, 24, 1552–1557 CrossRef CAS.
  36. T. Kurahashi, Inorg. Chem., 2015, 54, 8356–8366 CrossRef CAS PubMed.
  37. Z. Li, Y. Liu, Q. Xia and Y. Cui, Chem. Commun., 2017, 53, 12313–12316 RSC.
  38. B. Cheng, F. Cukiernik, P. H. Fries, J.-C. Marchon and W. R. Scheidt, Inorg. Chem., 1995, 34, 4627–4639 CrossRef CAS.
  39. (a) D. Sil, S. Bhowmik, F. S. T. Khan and S. P. Rath, Inorg. Chem., 2016, 55, 3239–3251 CrossRef CAS PubMed; (b) D. Sil, F. S. T. Khan and S. P. Rath, Chem. – Eur. J., 2016, 22, 14585–14597 CrossRef CAS PubMed.
  40. M. J. Baldwin, T. L. Stemmler, P. J. Riggs-Gelasco, M. L. Kirk, J. E. Penner-Hahn and V. L. Pecoraro, J. Am. Chem. Soc., 1994, 116, 11349–11356 CrossRef CAS.
  41. B. Cheng, P. H. Fries, J.-C. Marchon and W. R. Scheidt, Inorg. Chem., 1996, 35, 1024–1032 CrossRef CAS PubMed.
  42. V. Krewald, B. Lassalle-Kaiser, T. T. Boron, C. J. Pollock, J. Kern, M. A. Beckwith, V. K. Tachandra, V. L. Pecoraro, J. Yano, F. Neese and S. DeBeer, Inorg. Chem., 2013, 52, 12904–12914 CrossRef CAS PubMed.
  43. J. F. J. Dippy and R. H. Lewis, J. Chem. Soc., 1936, 1936, 644–649 RSC.
  44. F. G. Bordwell, Acc. Chem. Res., 1988, 21, 456–463 CrossRef CAS.
  45. (a) H. Torayama, T. Nishide, H. Asada, M. Fujiwara and T. Matsushita, Polyhedron, 1998, 17, 105–118 CrossRef CAS; (b) H. Torayama, H. Asada, M. Fujiwara and T. Matsushita, Polyhedron, 1998, 17, 3859–3874 CrossRef CAS; (c) N. A. Law, J. W. Kampf and V. L. A. Pecoraro, Inorg. Chim. Acta, 2000, 297, 252–264 CrossRef CAS.
  46. B. C. Schardt, F. J. Hollander and C. L. Hill, J. Am. Chem. Soc., 1982, 104, 3964–3972 CrossRef CAS.
  47. M. C. Biesinger, B. P. Payne, A. P. Grosvenor, L. W. M. Lau, A. R. Gerson and R. S. C. Smart, Resolving surface chemical states in XPS analysis of first row transition metals, oxides and hydroxides: Cr, Mn, Fe, Co and Ni, Appl. Surf. Sci., 2011, 257, 2717–2730 CrossRef CAS.
  48. P. J. Pospisil, D. H. Carsten and E. N. Jacobsen, Chem. – Eur. J., 1996, 2, 974–980 CrossRef CAS.
  49. S. Bhaduri, A. J. Tasiopoulos, M. A. Bolcar, K. A. Abboud, W. E. Streib and G. Christou, Inorg. Chem., 2003, 42, 1483–1492 CrossRef CAS PubMed.
  50. D. A. Pantazis, V. Krewald, M. Orio and F. Neese, Dalton Trans., 2010, 39, 4959–4967 RSC.
  51. C. Arunkumar, Y.-M. Lee, J. Y. Lee, S. Fukuzumi and W. Nam, Chem. – Eur. J., 2009, 15, 11482–11489 CrossRef CAS PubMed.
  52. (a) CCDC 2483878: Experimental Crystal Structure Determination, 2025,  DOI:10.5517/ccdc.csd.cc2pcp3w; (b) CCDC 2483879: Experimental Crystal Structure Determination, 2025,  DOI:10.5517/ccdc.csd.cc2pcp4x; (c) CCDC 2483880: Experimental Crystal Structure Determination, 2025,  DOI:10.5517/ccdc.csd.cc2pcp5y; (d) CCDC 2483881: Experimental Crystal Structure Determination, 2025,  DOI:10.5517/ccdc.csd.cc2pcp6z; (e) CCDC 2483882: Experimental Crystal Structure Determination, 2025,  DOI:10.5517/ccdc.csd.cc2pcp70.

This journal is © The Royal Society of Chemistry 2026
Click here to see how this site uses Cookies. View our privacy policy here.